Direct Answer
This timeline highlights milestones that shaped Amgen Inc. (AMGN)'s business model, competitive position, and investment thesis.
Key Milestones
| Year | Milestone |
|---|---|
| 1980 | The company was founded as Applied Molecular Genetics, later adopting the name Amgen. |
| 1980s | Amgen advanced recombinant-DNA medicines that helped establish biotechnology as a commercial industry. |
| 1989 | A major anemia therapy received U.S. approval, becoming one of the company's foundational products. |
| 1990s-2010s | Amgen expanded across supportive cancer care, inflammation, bone health, cardiovascular disease, and other areas. |
| 2023 | Amgen completed its acquisition of Horizon Therapeutics, materially expanding its rare-disease portfolio. |
Why the Chronology Matters
The timeline should emphasize events that changed the business model, segment comparability, competitive position, capital structure, or investment thesis. Link major acquisitions, divestitures, regulatory events, and platform transitions to dedicated Swoopr case studies where available.
Frequently Asked Questions
What are the most important milestones in Amgen Inc.'s history?
The most significant milestones for Amgen Inc. are those that changed the business model, created or disrupted a competitive advantage, altered segment comparability, or reset the investment thesis.
Why does the company timeline matter for Amgen Inc. investors?
The Amgen Inc. timeline matters because it explains how the current business model was constructed. Understanding when key decisions were made helps investors assess which competitive advantages are durable.
How has Amgen Inc.'s business model evolved over time?
Amgen Inc.'s business model has evolved through product transitions, market expansions, and strategic decisions. Each major transition changed revenue mix, margin structure, and capital requirements.